Collaboration - December 19, 2014
Xencor, Novo Nordisk Team Up
Biopharmaceutical company Xencor, Inc. announced that it has entered a collaboration agreement with Novo Nordisk to discover new drug candidates by combining Xencor XmAb technologies. The research and development deal has the potential to bring in $175 million for Xencor. Both companies will use the bispecific technology to build molecular formats that can target and […]
Uncategorized - December 18, 2014
Xellia Forms Advisory Board
Xellia Pharmaceuticals, which focuses on providing important anti-infective treatments against serious and often life-threatening infections, announced the formation of a new Scientific Advisory Board (SAB). The SAB brings together leading international scientific and clinical advisors with expertise in infectious diseases, clinical microbiology, respiratory medicines and drug research and development. The SAB Chairman will be Professor […]
Companies - December 18, 2014
Veloxis Files Suit Against FDA
Denmark’s Veloxis Pharmaceuticals A/S announced that it has filed an action in federal district court for the District of Columbia against the U.S. Food and Drug Administration, seeking an order requiring the FDA to grant final approval to Envarsus® XR. Envarsus XR is a once-daily extended-release tablet indicated for prophylaxis of organ rejection in kidney […]
Companies - December 18, 2014
AstraZeneca Closing UK Facility
As AstraZeneca continues restructuring, it is closing yet another facility, this one in Avonmouth, U.K. The plant is scheduled to close in 2016 or 2017, eliminating more than 250 skilled jobs. “I understand the business reasons behind the decision but at the same time it’s a great shame the entire plant is closing down,” said Darren […]
Companies - December 17, 2014
Aerocrine Bd. Member Resigns
Aerocrine AB announced that board member Staffan Lindstrand resigned. Lindstrand is also a board member of Healthcap, where he also is a partner, pharmaceutical company Orexo, Medtech company Pulmonx and eye laser company 20/10 Perfect Vision. He is a civil engineer with 10 years of experience in investment banking. Prior to this announcement, Aerocrine also […]
Uncategorized - December 17, 2014
R&D Profits Increase for Swedish Companies
The profits of Swedish pharmaceutical companies linked to research and development, (R&D) this year landed at 5.5 percent, an increase from 5.1 percent last year and it is the first time there was an increase since 2010. This is according to a new study in which the 12 largest life science companies ‘ spending on […]
